Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00363
|
|||||
| Drug Name |
Baloxavir marboxil
|
|||||
| Synonyms |
(((R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate; Baloxavir marboxil; Baloxavir marboxil (JAN/INN); Baloxavir marboxil [INN]; Xofluza (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Influenza A infection [ICD11: 1.00E+31] | Approved | [1] | |||
| Therapeutic Class |
Antiviral Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C27H23F2N3O7S
|
|||||
| Canonical SMILES |
COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F
|
|||||
| InChI |
InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1
|
|||||
| InChIKey |
RZVPBGBYGMDSBG-GGAORHGYSA-N
|
|||||
| CAS Number |
CAS 1985606-14-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 571.6 | Topological Polar Surface Area | 123 | ||
| Heavy Atom Count | 40 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 12 | |||
| XLogP |
3.8
|
|||||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Gadobenate dimeglumine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Baloxavir Marboxil FDA label | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.